Daisuke Nishi Selected Research

Accidental Injuries

12/2017	Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial.
1/2015	Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.
1/2013	Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.
1/2011	Potential role of brain-derived neurotrophic factor in omega-3 Fatty Acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study.
4/2010	Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study.
4/2009	The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daisuke Nishi Research Topics

Disease

15	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2017 - 01/2009
6	Accidental Injuries 12/2017 - 04/2009
3	Major Depressive Disorder (Major Depressive Disorders) 01/2016 - 01/2013
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2017
2	Wounds and Injuries (Trauma) 12/2017 - 01/2013
2	Poisoning 08/2017 - 08/2015
1	Depressive Disorder (Melancholia) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Hemorrhage 11/2021
1	Postpartum Depression (Post-Natal Depression) 04/2021
1	Heart Failure 08/2017
1	Acute Coronary Syndrome 01/2017
1	Substance-Related Disorders (Drug Abuse) 12/2015
1	Malnutrition (Nutritional Deficiencies) 03/2015

Drug/Important Bio-Agent (IBA)

7	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 04/2010
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2017 - 01/2009
3	Docosahexaenoic AcidsIBA 12/2017 - 01/2015
3	Eicosapentaenoic AcidIBA 12/2017 - 01/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 01/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2016
2	Pharmaceutical PreparationsIBA 08/2017 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2013
1	CurcuminIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	AshwagandhaIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	ZincIBA 01/2022
1	MicronutrientsIBA 01/2022
1	Acetylcarnitine (Alcar)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 11/2021
1	BenzodiazepinesIBA 08/2017
1	Cardiovascular AgentsIBA 08/2017
1	Linoleic Acid (Linoleate)IBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 12/2015
1	Biological ProductsIBA 12/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2015
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2015
1	Neuropeptide YIBA 06/2014
1	Propofol (Diprivan)FDA LinkGeneric 10/2012
1	Fish OilsIBA 12/2011

Therapy/Procedure

5	Secondary Prevention 12/2017 - 04/2010
2	Therapeutics 04/2021 - 03/2015
1	Diet Therapy (Therapy, Diet) 12/2015
1	Critical Care (Surgical Intensive Care) 04/2009